Titelia

Holdings of Atle Fund Management AB

37 declared positions · as of Mar 31, 2026

Original filing · Ten largest lines: 47.6 % of the equity sleeve

Sector breakdown

  • Health care 61.4 %
  • Industrials 3.2 %
  • Materials 2.7 %
  • Unattributed 32.7 %

Titelia classification, company by company. The unattributed share stays visible.

Currency breakdown

  • USD 100.0 %

The quoted currency of each line, as declared.

Country breakdown

  • US 98.4 %
  • FR 1.6 %

Shares computed on the equity sleeve.

RankCountryLinesValueShare
1US36291.2M $98.38 %
2FR14.8M $1.62 %

Positions

RankCompanySharesValueWeight
1Eli Lilly & Co 39,72226.8M $
2Merck & Co Inc 33,85322.9M $
3Thermo Fisher Scientific Inc 22,98614.4M $
4BEONE MEDICINES LTD 41,71712.1M $
5Johnson & Johnson 92,37711.9M $
6Bridgebio Pharma Inc 111,36311.9M $
7Vertex Pharmaceuticals Inc 22,98411.2M $
8AbbVie Inc 108,18110.4M $
9Stryker Corp 26,8359.6M $
10Intuitive Surgical Inc 70,8519.4M $
11Ionis Pharmaceuticals Inc 27,8739.4M $
12Mirum Pharmaceuticals Inc 195,7689.4M $
13CVS Health Corp 23,7739.3M $
14Revolution Medicines Inc 617,2459.1M $
15Boston Scientific Corp 40,4328.8M $
16Amgen Inc 21,9038.7M $
17Edwards Lifesciences Corp 106,5188.3M $
18Incyte Corp 50,7968M $
19Neurocrine Biosciences Inc 89,6857.9M $
20Gilead Sciences Inc 47,9677.2M $
21Krystal Biotech Inc 37,5796.8M $
22Cencora Inc 23,4706.6M $
23IRhythm Holdings Inc 22,3226.3M $
24Insmed Inc 97,4386M $
25Celcuity Inc 141,2965.1M $
26Abivax SA 31,5904.8M $
27Cardinal Health, Inc. 108,6824.8M $
28Ideaya Biosciences Inc 31,1334M $
29Tango Therapeutics Inc 29,9153.6M $
30Spyre Therapeutics Inc 62,7353.5M $
31Disc Medicine Inc 107,2553.2M $
32Compass Therapeutics Inc 41,8313.1M $
33UnitedHealth Group Inc 14,6362.8M $
34Dexcom Inc 584,3322.6M $
35Bicara Therapeutics Inc 1,169,6342.3M $
36Soleno Therapeutics Inc 90,1842.2M $
37Pyxis Oncology Inc 197,0361.6M $